BRIEF-Momenta provides year-end 2016 corporate update By: Reuters: Company News January 06, 2017 at 08:08 AM EST * Momenta Pharmaceuticals Inc - reiterated its non-gaap operating expense guidance of approximately $40 - $45 million for Q4 of 2016 Read More >> Related Stocks: Momenta Pharma